ArticleScience advances2026

Mutant p53 sensitizes KRAS-driven lung adenocarcinoma to immunotherapy by repressing SPP1.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.